Rosen et al. [23] found that Alzheimer’s disease patients had increased CSF levels of YKL-40 of approximately twice that of controls who had normal CSF profiles of core Alzheimer’s disease biomarkers. The gene discussed is CHI3L1; the disease is early-onset autosomal dominant Alzheimer disease.